Novocure Ltd at Evercore ISI HealthCONx Conference (Virtual) - Fireside Chat Transcript
Okay. Thanks, everyone, for joining us this morning. Very pleased to have NovoCure with us. I mean it's a fascinating story. As far as TAM stories go, NovoCure is probably one of the best TAM stories out there. To tell us more about the company, we have Bill Doyle, Chairman of the company; and their Chief Scientific Officer, Uri Weinberg. Bill and Uri, thank you for joining us this morning.
Questions & Answers
Maybe let's start on that theme, Bill. I put on my simplistic device hat, right, and sometimes it gets confusing. Is this a biotech stock? Is this a device stock? It has elements of both. And how would you classify the company? Maybe for some people who are not familiar with the story, give an overview of the technology and what it does.
Sure. So thanks, Vijay. And thanks for having
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
